Evidence map›Paper›PMID 41054653›Full record

ArticleCureus2025

Improving Safe Initiation of Direct Oral Anticoagulant Therapy: A Two-Cycle Quality Improvement Project.

Orzo Shrestha, Honey Joshi, Shwe San, James Richards

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Orzo ShresthaCardiology, Royal Bournemouth Hospital, Bournemouth, GBR.
Honey JoshiGeriatrics, Poole General Hospital, Poole, GBR.
Shwe SanGastroenterology, Poole General Hospital, Poole, GBR.
James RichardsStroke Medicine, Dorset County Hospital, Dorchester, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Direct oral anticoagulants (DOACs) are increasingly used for stroke prevention in atrial fibrillation and treatment of venous thromboembolism. However, DOACs are high-risk medications; inappropriate prescribing or dosing can lead to adverse outcomes. This quality improvement (QI) project aimed to standardize the DOAC initiation process at a district general hospital to enhance prescribing safety and reduce errors. Methodology A multidisciplinary team conducted two Plan-Do-Study-Act (PDSA) cycles.

Indexed as

anticoagulation safetydirect oral anticoagulant (doac)doac prescribing errorspatient counsellingprescribing standardizationprevention of strokequality improvement projectsvenous thromboembolism

Identifiers

PMID41054653
PMCPMC12496554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.